fda approved glp-1 drugs for weight loss Wegovy Pill Wins Approval as First Oral Treatment Obesity and FDA approves Foundayo, an oral
Description
In a separate meta-analysis, a significantly increased risk of cholelithiasis (OR 1.30

The relative influences of other factors on discontinuation are unclear, including changes in insurance coverage, high out-of-pocket costs, medication shortages [71], or false cessation due to switching to compounded (pharmacy prepared) GLP-1s

The researchers didnt account for income, exercise, alcohol use, family history, genetic risk, or other medications

Thats the real victory.
Widespread access to GLP-1s for weight loss would be financially unsustainable for many employers

For me, its unprecedented in terms of how much insurance matters for the clinical care that Im providing and the choices that I have, she said
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)